Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
December 18, 2024
12:00 PM - 01:30 PM ET
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
February 14, 2025
06:00 PM - 08:00 PM PST
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
ns-MRAs and eGFR Slope: The Kidney Perspective
ns-MRAs and eGFR Slope: The Kidney Perspective
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
Advances in the Treatment and Management of MASH: More Options, More Decisions
Advances in the Treatment and Management of MASH: More Options, More Decisions
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC
Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC
Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings
Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings
